A post hoc multivariate analysis for OS using known prognostic factors supported the primary results ( HR : 0.74 [ 95 % CI , 0.61-0 .89 ] ; p = 0.0017 ) , and all clinically relevant secondary end points and patient-reported outcomes improved .